The global microsurgical robotic system market size was USD 1.43 billion in 2023, estimated at USD 1.61 billion in 2024 and is anticipated to reach around USD 5.22 billion by 2034, expanding at a CAGR of 12.49% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Microsurgical Robotic System Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Microsurgical Robotic System Market Revenue and Volume, by Application, 2024-2034
8.1.1. Ophthalmology Surgery
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Cardiovascular Surgery
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Neurovascular Surgery
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Gastrointestinal Surgery
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Obstetrics and Gynecology Surgery
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
8.1.6. Urology Surgery
8.1.6.1. Market Revenue and Volume Forecast (2021-2034)
8.1.7. Oncology Surgery
8.1.7.1. Market Revenue and Volume Forecast (2021-2034)
8.1.8 ENT Surgery
8.1.8.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Microsurgical Robotic System Market Revenue and Volume, by End-use, 2024-2034
9.1.1. Hospitals and Clinics
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Research Institutes
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.1. Intuitive Surgical, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Medtronic plc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Stryker Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Zimmer Biomet Holdings, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Accuray Incorporated
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Smith & Nephew plc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. TransEnterix Surgical, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Renishaw plc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Medrobotics Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Titan Medical Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample